Recently published data confirm decisiondx®-scc as a significant and independent risk-stratification tool in patients with squamous cell carcinoma and one or more risk factors

Friendswood, texas--(business wire)---- $cstl #cstl--castle announced the publication of clinical performance study data related to decisiondx®-scc in future oncology.

CSTL Ratings Summary

CSTL Quant Ranking